Your session is about to expire
← Back to Search
Laser Therapy
CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces. for Solar Elastosis
N/A
Waitlist Available
Research Sponsored by Bausch Health Americas, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post treatment, up to 7 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a laser treatment that uses two types of light to help people with sun-damaged skin. The treatment encourages the skin to repair itself and grow new cells, making it look fresher and younger. Laser therapy is a new approach to treating cosmetic and medical skin conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post treatment, up to 7 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post treatment, up to 7 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean Improvement in Photoaging Damage Appearance at 3 Months Post Treatment
Secondary study objectives
Mean Improvement in Photoaging Damage Appearance at 1 Month Post Treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpiecesExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CLEAR + BRILLIANT TOUCH(R) 1440-nm and 1927-nm handpieces.
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Bausch Health Americas, Inc.Lead Sponsor
262 Previous Clinical Trials
81,902 Total Patients Enrolled
2 Trials studying Solar Elastosis
61 Patients Enrolled for Solar Elastosis
Anya LoncaricStudy DirectorBausch Health
39 Previous Clinical Trials
20,635 Total Patients Enrolled
Varsha BhattStudy DirectorBausch Health
8 Previous Clinical Trials
1,011 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger